Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
American Regent, Inc.
This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron (ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with non-dialysis dependent chronic kidney disease (NDD-CKD).
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females \> or = 12 years of age
NDD-CKD subjects
Baseline hemoglobin \< or = 11g/dl
Stable erythropoietin (EPO) status
You may not be if
Known hypersensitivity to ferrous sulfate or IV iron
Unstable EPO status
Anemia not related to CKD
Chronic, serious infection
Recent IV iron
Recent blood transfusion
Recent blood loss
Need for surgery
Received investigational drug within 30 days
Female subjects who are pregnant or lactating
Clareo Health | VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
